Coherus BioSciences Inc (CHRS) — Working Capital to Net Assets Ratio
Coherus BioSciences Inc (CHRS) has a Working Capital to Net Assets ratio of 95.8% as of June 2026. Working capital of $58.28 Million (current assets of $133.79 Million minus current liabilities of $75.51 Million) is measured against net assets of $60.84 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See CHRS cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Coherus BioSciences Inc Working Capital to Net Assets (2012–2025)
This chart shows how Coherus BioSciences Inc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 95.8%, reflecting working capital of $58.28 Million against net assets of $60.84 Million USD. For the complete balance sheet picture, see Coherus BioSciences Inc assets under control.
Annual Working Capital to Net Assets for Coherus BioSciences Inc (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Coherus BioSciences Inc from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Coherus BioSciences Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 106.3% | $64.83 Million | $61.01 Million | $206.71 Million | $141.88 Million | ▲ +150.7 pp |
| 2024 | -44.4% | $58.60 Million | $-131.99 Million | $341.58 Million | $282.98 Million | ▲ +30.0 pp |
| 2023 | -74.4% | $143.86 Million | $-193.43 Million | $475.63 Million | $331.77 Million | ▲ +102.1 pp |
| 2022 | -176.5% | $242.54 Million | $-137.42 Million | $381.23 Million | $138.69 Million | ▼ -623.7 pp |
| 2021 | 447.2% | $437.00 Million | $97.73 Million | $602.32 Million | $165.33 Million | ▲ +225.9 pp |
| 2020 | 221.3% | $621.83 Million | $280.97 Million | $767.48 Million | $145.65 Million | ▼ -25.6 pp |
| 2019 | 246.9% | $259.76 Million | $105.21 Million | $374.73 Million | $114.97 Million | ▲ +348.2 pp |
| 2018 | -101.3% | $39.09 Million | $-38.59 Million | $72.36 Million | $33.26 Million | ▼ -423.9 pp |
| 2017 | 322.6% | $98.52 Million | $30.54 Million | $126.91 Million | $28.39 Million | ▼ -31.7 pp |
| 2016 | 354.3% | $68.57 Million | $19.35 Million | $124.95 Million | $56.38 Million | ▲ +1107.8 pp |
| 2015 | -753.5% | $52.21 Million | $-6.93 Million | $158.23 Million | $106.02 Million | ▼ -901.2 pp |
| 2014 | 147.7% | $98.61 Million | $66.76 Million | $150.39 Million | $51.78 Million | ▲ +128.8 pp |
| 2013 | 18.9% | $-8.02 Million | $-42.38 Million | $45.68 Million | $53.70 Million | ▼ -128.4 pp |
| 2012 | 147.4% | $13.55 Million | $9.19 Million | $24.80 Million | $11.25 Million | — |